Efficacy and safety of alirocumab once-monthly in patients with atherosclerotic cardiovascular disease and without history of an acute atherothrombotic event

Tokgözöğlu L., Arbel Y., Lozano C. B., Martens F., Stach K., Orsini M., ...Daha Fazla

American Journal of Preventive Cardiology, 2026 (ESCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.ajpc.2026.101752
  • Dergi Adı: American Journal of Preventive Cardiology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Anahtar Kelimeler: Alirocumab, Atherosclerotic cardiovascular disease, Cardiovascular prevention, LDL-cholesterol, Once-monthly dosing, PCSK9 inhibitor
  • Hacettepe Üniversitesi Adresli: Evet